Table 6.

ISCL/USCLC/EORTC global disease response score in primary cutaneous lymphomas

Global score*	Definition	Skin	Lymph nodes	Viscera	Blood
CR	Complete disappearance of all clinical evidence of disease	CR	All categories involved at baseline have CR/NI
PR	Partial regression of measurable disease	CR	All categories involved do not have a CR/NI and no category has a PD
		PR	No category has a PD and if any category involved at baseline, at least one has a PR or CR
SD	Failure to attain CR, PR or PD representative of all disease	PR	No category has a PD and if any category involved at baseline, no CR or PR if any
		SD	CR/NI, PR, SD in any category and no category has a PD
PD	Progressive disease	PD in any category

Modified from Olsen et al⁸ and Kempf et al.¹⁰ This table assumes that (1) all patients at baseline have measurable skin disease and (2) in patients with PCL and no extracutaneous disease at baseline, any new nodal or visceral involvement constitutes PD in those compartments.

NI, noninvolved; SD, stable disease.

^*This assumes that the response (CR, PR, SD, PD, or relapse) has been maintained for at least 4 weeks in any involved category.